Antibody Treatment Shows Promise in Protecting Infants from RSV
A one-time antibody injection against RSV is available for infants in some countries
Shutterstock / Anatta_Tan
An antibody treatment for respiratory syncytial virus (RSV) has shown promising results in protecting infants from severe illness compared to vaccination during pregnancy.
According to the World Health Organization, approximately 100,000 children under the age of 5 die from RSV each year. Currently, there are only two main methods to immunize infants against the virus. The first involves administering a vaccine during pregnancy, which transfers antibodies to the fetus and provides protection for the first six months of life. The second method is a one-time antibody injection…
